|
Brain Metastases in Breast Cancer Network Germany (BMBC; GBG 79): Multicentric, retro- and prospective collection of patient data and biomaterial from patients with brain metastases. |
|
|
Honoraria - Amgen; Celgene; Eisai; GlaxoSmithKline; Pierre Fabre; Roche Pharma AG; Teva |
Consulting or Advisory Role - Celgene; Eisai; Pierre Fabre; Roche Pharma AG; Teva |
|
|
No Relationships to Disclose |
|
|
Honoraria - Roche Pharma AG |
Consulting or Advisory Role - Roche Pharma AG |
|
|
No Relationships to Disclose |
|
|
Employment - GBG Forschungs |
Leadership - GBG Forschungs |
Stock and Other Ownership Interests - GBG Forschungs |
Research Funding - Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Celgene (Inst); GlaxoSmithKline (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Sanofi (Inst); Teva (Inst) |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |